Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers

Trial Profile

Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers

Status: Withdrawn prior to enrolment
Phase of Trial: Phase I/II

Latest Information Update: 25 May 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Atomoxetine (Primary)
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 May 2017 Status changed from suspended to withdrawn prior to enrolment.
    • 17 Feb 2015 Status changed from recruiting to suspended due to funding as reported by ClinicalTrials.gov record.
    • 03 May 2014 Status changed from not yet recruiting to recruiting, as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top